Arterial hypertension and gout: the current state of the problem (literature review).
DOI:
https://doi.org/10.26641/2307-0404.2017.4.117662Ключевые слова:
arterial hypertension, gout, antihypertensive drugs, urat-lowering therapyАннотация
An important aspect of the family doctor's work is the management of patients with comorbid pathology. Pathogenetic mechanisms of interrelation, as well as the bi-directionality of the association of arterial hypertension and gout are actively studied. By data analysis of literature, in many developed countries of the world there are shortcomings in the management of patients with gout at the primary stage. There is a need to improve the quality of management and prescription of combinations of basic therapy drugs for the treatment of patients with hypertension in combination with gout at the primary stage.
Библиографические ссылки
Antyuk ZhO. [State of lipid metabolism in patients with gout]. Vіsnik SumDU. 2010;2:52-55. Ukrainian.
Ivanova KV. [Rational treatment of arterial hypertension in patients with gout and asymptomatic hyperuricemia in a polyclinic. Extended abstract of candidate’s thesis].Orenburg; 2013. Russian.
Il'ina AE, Barskova VG, Nasonov EL. [Gout, hyperuricemia and cardiovascular risk]. Nauchno-prakticheskaya revmatologiya. 2009;1:56-62. Russian.
Tsurko VV, Egorov IV, Eliseeva MV. [Gout: cardiovascular pathology and antihypertensive therapy]. Klinicheskaya gerontologiya. 2013;19(1-2):3-7. Russian.
Yakimenko OO, ZakatovaLV, Antіpova NM. [Dynamics of the structure of rheumatic diseases for 30 years (1983-2013) inOdessa]. Ukraїns'kiy revmatologіchniy zhurnal. 2014;57(3):94-95. Ukrainian.
McAdams-DeMarco MA, Maynard JW, Baer AN, et al. Hypertension and the risk of incident gout in a population-based study: the atherosclerosis risk in communities cohort. J Clin Hypertens (Greenwich). 2012;14(10):675-9.
Agarwal V, Hans N, Messerli FH. Effect of allopurinol on blood pressure: a systematic review and meta-analysis. J Clin Hypertens (Greenwich). 2013;15(6):435-42.
Kok VC, Horng JT, Chang WS, et al. Allopurinol therapy in gout patients does not associate with beneficial cardiovascular outcomes: a population-based matched-cohort study. PLoS One. 2014;9(6):e99102. doi: 10.1371/journal.pone.0099102.
Hsu PF, Chuang SY, Cheng HM, et al. Associations of serum uric acid levels with arterial wave reflections and central systolic blood pressure. Int J Cardiol. 2013;168(3):2057-63.
Choi HK, Soriano LC, Zhang Y, et al. Antihypertensive drugs and risk of incident gout among patients with hypertension: population based case-control study. BMJ. 2012;344:d8190.
Krishnan SM, Sobey CG, Latz E, et al. IL-1β and IL-18: inflammatory markers or mediators of hypertension? Br J Pharmacol. 2014;171(24):5589-602.
Jeyaruban A, Larkins S, Soden M. Management of gout in general practice – a systematic review. Clin Rheumatol. 2015;34(1):9-16.
Juraschek SP, Kovell LC, Miller ER, et al. Dose-response association of uncontrolled blood pressure and cardiovascular disease risk factors with hyperuricemia and gout. PLoS One. 2013;8(2):e56546. doi: 10.1371/journal.pone.0056546.
Pillinger MH, Goldfarb DS, Keenan RT. Gout and Its Comorbidities. Bull NYU Hospit J Dis. 2010;68(3):199-203.
Robinson PC, Taylor WJ, Dalbeth N. An Observational Study of Gout Prevalence and Quality of Care in a National Australian General Practice Population. J Rheumatol. 2015;42(9):1702-7.
Rodriguez-Iturbe B, Franco M, Tapia E, et al. Renal inflammation, autoimmunity and salt-sensitive hypertension. Clin Exp Pharmacol Physiol. 2012;39:96-103.
Ruilope LM, Kirwan BA, de Brouwer S, et al. Uric acid and other renal function parameters in patients with stable angina pectoris participating in the ACTION trial: impact of nifedipine GITS (gastro-intestinal therapeutic system) and relation to outcome. J Hypertens. 2007;25(8):1711-8.
Terrill M, Riordan J. A survey of the assessment and management of gout in general practitioners and medical officers within the IllawarraNetwork,Australia. Int J Rheum Dis. 2017;20(8):990-5.
Turak O, Ozcan F, Tok D, еt al. Serum uric acid, inflammation, and nondipping circadian pattern in essential hypertension. J Clin Hypertens (Greenwich). 2013;15(1):7-13.
Richette P, Doherty M, Pascual E, et al. 2016 updated EULAR evidence-based recommendations for the management of out. Annals of the Rheumatic Diseases. 2016. Available from: http://ard.bmj.com/content/early/2016/07/25/annrheumdis-2016-209707.full.pdf+html.
Yu FN, Shi YX, Cheng HY, et al. An observational study on the relationship between serum uric acid and hypertension in a Northern Chinese population aged 45 to 59 years. Medicine (Baltimore). 2017;96(17).e6773. doi: 10.1097/MD.0000000000006773.
Загрузки
Как цитировать
Выпуск
Раздел
Лицензия
Copyright (c) 2017 Medicni perspektivi (Medical perspectives)
Это произведение доступно по лицензии Creative Commons «Attribution» («Атрибуция») 4.0 Всемирная.
Submitting manuscript to the journal "Medicni perspektivi" the author(s) agree with transferring copyright from the author(s) to publisher (including photos, figures, tables, etc.) editor, reproducing materials of the manuscript in the journal, Internet, translation into other languages, export and import of the issue with the author’s article, spreading without limitation of their period of validity both on the territory of Ukraine and other countries. This and other mutual duties of the author and all co-authors separately and editorial board are secured by written agreement by special form to use the article, the sample of which is presented on the site.
Author signs a written agreement and sends it to Editorial Board simultaneously with submission of the manuscript.
